"Biological Products" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay.
| Descriptor ID |
D001688
|
| MeSH Number(s) |
D20.215
|
| Concept/Terms |
Biological Products- Biological Products
- Biologic Products
- Products, Biologic
- Biologics
- Products, Biological
|
Below are MeSH descriptors whose meaning is more general than "Biological Products".
Below are MeSH descriptors whose meaning is more specific than "Biological Products".
This graph shows the total number of publications written about "Biological Products" by people in this website by year, and whether "Biological Products" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2013 | 1 | 2 | 3 |
| 2014 | 3 | 1 | 4 |
| 2015 | 3 | 1 | 4 |
| 2016 | 2 | 1 | 3 |
| 2017 | 90 | 33 | 123 |
| 2018 | 110 | 37 | 147 |
| 2019 | 53 | 16 | 69 |
| 2020 | 64 | 16 | 80 |
| 2021 | 23 | 10 | 33 |
To return to the timeline, click here.
Below are the most recent publications written about "Biological Products" by people in Profiles.
-
ImmTORTM to amplify the efficacy and reduce immunogenicity of biologics. Emerg Top Life Sci. 2021 11 12; 5(5):597-600.
-
Safety and antibody response after one and/or two doses of BNT162b2 Anti-SARS-CoV-2 mRNA vaccine in patients treated by CAR T cells therapy. Br J Haematol. 2022 01; 196(2):360-362.
-
Dermatology practice in the times of the COVID-19 pandemic. Indian J Dermatol Venereol Leprol. 2021 Sep-Oct; 87(5):603-610.
-
Biologics may have a beneficial effect in asthma patients with COVID-19. Eur Respir J. 2021 08; 58(2).
-
Dermatology patients on biologics and certain other systemic therapies should receive a "booster" messenger RNA COVID-19 vaccine dose: A critical appraisal of recent Food and Drug Administration and Advisory Committee on Immunization Practices recommendations. J Am Acad Dermatol. 2021 Nov; 85(5):1113-1116.
-
Pharmacophore-Based Virtual Screening, Quantum Mechanics Calculations, and Molecular Dynamics Simulation Approaches Identified Potential Natural Antiviral Drug Candidates against MERS-CoV S1-NTD. Molecules. 2021 Aug 17; 26(16).
-
Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry. Pharmacol Res. 2021 10; 172:105820.
-
Antiviral fungal metabolites and some insights into their contribution to the current COVID-19 pandemic. Bioorg Med Chem. 2021 09 15; 46:116366.
-
Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course. J Cosmet Dermatol. 2021 Oct; 20(10):3098-3102.
-
COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: Review of available evidence. J Am Acad Dermatol. 2021 Nov; 85(5):1274-1284.